ImmuCell Corporation (ICCC) Short Interest
Nasdaq • ICCC • US4525253062
As of Oct 27, 2026, ORTEX estimated 0.3% of free float sold short, 1.8 days to cover, cost to borrow 2%. Sign up for live short interest data.
Nasdaq • ICCC • US4525253062
As of Oct 27, 2026, ORTEX estimated 0.3% of free float sold short, 1.8 days to cover, cost to borrow 2%. Sign up for live short interest data.
This page tracks how heavily ImmuCell Corporation (Nasdaq:ICCC) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
ImmuCell Corporation (Nasdaq: ICCC) has a market capitalization of $92.53M. Last close $10.19 (as of 2026-11-12); 52-week range $4.52 to $12.10. ORTEX data as of 2026-10-27: short interest was 0.29% of free float, 1.8 days to cover and the average cost to borrow was 2%. Sign up for live short interest data.